Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines

The global COVID-19 pandemic has led to a race to find medications that can improve the prognosis of the disease. Azithromycin, in association with hydroxychloroquine or chloroquine, has been proposed as one such medication. The aim of this review is to describe the pharmacological mechanism, clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Sultana, Janet, Cutroneo, Paola Maria, Crisafulli, Salvatore, Puglisi, Gabriele, Caramori, Gaetano, Trifirò, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371963/
https://www.ncbi.nlm.nih.gov/pubmed/32696429
http://dx.doi.org/10.1007/s40264-020-00976-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371963/
https://www.ncbi.nlm.nih.gov/pubmed/32696429
http://dx.doi.org/10.1007/s40264-020-00976-7

Ejemplares similares